SOUTHAMPTON, England, April 21 /PRNewswire/ -- Vantia Therapeutics, a company developing novel small molecule drugs targeting large underserved medical markets, today announces the appointment of Rachel Morten as Head of Regulatory Affairs.

Rachel has more than 24 years experience in global regulatory affairs and product development in the pharmaceutical and animal health industries. Most recently an independent regulatory affairs consultant, Rachel has also served as Senior Director, Group Head Regulatory Affairs for the international CRO Averion International Ltd (previously Hesperion). Previously Rachel founded ChapelPharma a regulatory consultancy that was acquired by Hesperion in 2004.

LAS VEGAS, April 21 /PRNewswire/ --

- Swarmcast powers Internet TV video for world's leading sports broadcaster

NAB -- Swarmcast, the leader in live sports Internet TV, announced today that Setanta Sports has partnered with Swarmcast to deliver Setanta's new online video offering, Setanta-i, bringing sports fans both live and on-demand video of Setanta programming, including the prestigious English Premier League.

The Setanta-i service offers live streams of all Setanta's main channels (varying by market) and brings a full screen, TV-like experience to viewers around the globe available on both a free and pay basis.

HSINCHU, Taiwan, April 21 /PRNewswire/ --

- Silicon-proven Reference Design Approach Accelerates RF Designs and Enables Systems-on-Chip Integration

Taiwan Semiconductor Manufacturing Company, Ltd. (TSE: 2330; NYSE: TSM) today unveiled the foundry industry's first Mixed Signal/Radio Frequency Reference Design Kit (MS/RF RDK) at its North American Technology Symposium in San Jose. The RDK initially targets 65nm process technology and aims to accelerate analog, mixed-signal, and RF designs and RF SoC verification and integration. The MS/RF RDK is the result of multi-year collaboration between TSMC and Cadence Design Systems and represents one of the initial deliverables of the TSMC Open Innovation Platform(TM).

HSINCHU, Taiwan, April 21 /PRNewswire/ --

- Open Innovation Platform Drives First Comprehensive and Executable RTL To GDSII Design Flow

Taiwan Semiconductor Manufacturing Company, Ltd. (TSE: 2330, NYSE: TSM) today unveiled the first foundry-specific Integrated Sign-Off Flow at its North American Technology Symposium in San Jose, CA. The new flow is available now for 65nm designs.

CARY, North Carolina, April 21 /PRNewswire/ --

- First Ever Operational 300mm Fab Available For Purchase in the U.S.

Qimonda North America Corporation today announced the appointment of advisors to assist in the sale of their semiconductor manufacturing assets in Sandston, Virginia, subject to bankruptcy court approval. The advisory team is comprised of ATREG, a division of Colliers International, Emerald Technology Valuations LLC and Gordon Brothers Commercial Industrial.

SINGAPORE, April 21 /PRNewswire/ --

- New Studies Advance the Development of Novel Vaccine for Dengue Prevention in Asia Pacific

SINGAPORE, April 21 /PRNewswire/ --

Sanofi Pasteur, the vaccines division of sanofi-aventis Group (EURONEXT : SAN and NYSE : SNY), announced today the start of clinical studies of its investigational tetravalent dengue vaccine in Singapore and Vietnam.

With these studies, sanofi pasteur is expanding its global dengue vaccine clinical study program in Asia where trials are already ongoing in Thailand and the Philippines. These studies are aimed at advancing the development of a novel vaccine for the prevention of dengue in the Asia-Pacific region.

GENEVA, April 21 /PRNewswire/ --

- First Drug in Europe Indicated for the Treatment of Hyperphenylalaninaemia (Hpa) due to Phenylketonuria (Pku) or Tetrahydrobiopterin (BH4) Deficiency, now Commercially Available in France, Germany and the United Kingdom

Merck Serono, a division of Merck KGaA, Darmstadt, Germany, today announced that Kuvan (sapropterin dihydrochloride), indicated for the treatment of hyperphenylalaninaemia (HPA) due to phenylketonuria (PKU) or tetrahydrobiopterin (BH4) deficiency, is now commercially available in Europe. Beginning with France, Germany and the United Kingdom, Kuvan will be rolled out in a total of thirteen European countries this year.

JERSEY CITY, New Jersey and LONDON, April 21 /PRNewswire/ --

Knight Capital Group, Inc. (Nasdaq: NITE) today announced the introduction of agency algorithmic trading and smart order execution strategies developed specifically for the European equity marketplace.

LONDON, April 21 /PRNewswire/ --

- First UK Gastric Band Operation Through The Belly Button

In a British medical first pioneering surgeon Professor Franco Favretti and his team have performed the UK's first SILS (Single Incision Laparoscopic Surgery) gastric band implantation.

This means overweight patients no longer have to undergo the usual five incisions for traditional laparoscopic gastric banding surgery, Professor Favretti performed the operation via a single incision through the belly button.

SILS is the next logical step in the progression of laparoscopic surgery and has several advantages for the patient:

LONDON, April 21 /PRNewswire/ -- A widespread confusion and ignorance about multiple sclerosis (MS) in the minds of the general public has been revealed in a new survey.

The results of the poll carried out for the MS Society highlight the many misconceptions that exist around the condition, and have been released ahead of next week's MS Week, during which the charity hopes to encourage better understanding among the public.

The You Gov poll shows that of the more than 2,000 questioned there was a lack of understanding of how common MS is, what its symptoms were and at what age it is generally diagnosed.